Overview

Detailed Summary

Apollo Hospitals Enterprise Ltd is a pan‑India integrated healthcare provider operating hospitals, diagnostics, primary care clinics, an omni‑channel pharmacy distribution network and a large digital healthcare platform, with a consolidated network that includes 76 hospitals, ~10,325 capacity beds and material subsidiaries Apollo HealthCo and AHLL delivering out‑of‑hospital care and retail diagnostics.
Q3 FY26 consolidated revenues grew 17% year‑on‑year to ₹64,774 million with EBITDA up 27% to ₹9,653 million and PAT up 35% to ₹5,023 million, driven by 14% healthcare services growth, 20% HealthCo revenue growth and AHLL diagnostics expansion; digital losses narrowed significantly and HealthCo cash profit doubled versus prior year.
Apollo is pursuing an aggressive capacity build and M&A agenda: a ~₹8,200 crore bed expansion pipeline to add ~4,444 beds over FY26–FY30, plus a composite scheme to spin and list the combined HealthCo/Keimed entity as NewCo, an initiative that reconfigures ownership and aims to unlock value through listing by Q4 FY27.
Digital and platform businesses are scaling: Apollo 24|7 reports ~46 million registered users and ~9.5 lakh daily active users, platform GMV grew ~28% in Q3 FY26, Apollo Pharmacy operates 7,113 stores, and Apollo is integrating AI, telehealth and insurance solutions to increase omni‑channel customer journeys and diagnostic/pharmacy penetration across India.

Sector: Healthcare
Industry: Hospitals / Medical Services
Market Cap: 1,10,231 Cr
Volatility: Low Risk
P/E Ratio: 61.2
Industry P/E: 60.2
PEG Ratio: 3.1
P/B Ratio: 12.1
52W High: 8,099.00
52W Low: 6,017.95

Sales CAGR

1Y: 14.35%
3Y: 10.38%
5Y: -3.49%
10Y: 4.36%

Profit CAGR

1Y: 60.97%
3Y: 31.31%
5Y: 22.49%
10Y: 16.26%

ROE

TTM: 18.39%
3Y: 14.06%
5Y: 13.16%
10Y: 11.19%

ROCE

TTM: 16.07%
3Y: 14.90%
5Y: 14.25%
10Y: 12.32%

Technicals

‌

Forecasts

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
APOLLOHOSP	7666.40	1,10,231 Cr	61.17	12.13	0.17	18.39	16.07	8.50
MAXHEALTH	1052.80	1,02,535 Cr	72.54	10.20	0.14	13.50	12.81	8.72
FORTIS	910.60	68,746 Cr	71.59	7.29	0.11	10.75	12.26	6.53
NH	1740.25	35,564 Cr	45.38	8.76	0.26	20.82	17.75	10.07
ASTERDM	649.55	33,655 Cr	102.40	8.04	0.74	8.18	10.11	4.60
MEDANTA	1105.05	29,840 Cr	57.84	8.05	0.00	15.15	16.83	9.50
KIMS	706.35	28,264 Cr	94.18	12.45	0.00	14.80	10.88	4.75

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	4,847	4,851	4,944	5,086	5,589	5,527	5,592	5,842	6,304	6,477
Expenses	4,219	4,237	4,303	4,411	4,774	4,765	4,823	4,990	5,362	5,512
Operating Profit	627	614	640	675	816	762	770	852	941	965
OPM %	12.95	12.65	12.96	13.27	14.59	13.78	13.76	14.58	14.93	14.90
Other Income	26	29	37	49	44	69	72	54	61	49
Interest	111	113	119	116	118	110	115	108	110	113
Depreciation	163	167	190	177	185	185	211	215	218	219
Profit Before Tax	379	363	368	430	557	536	516	583	675	682
Tax %	34.35	29.98	29.82	26.63	29.01	29.24	19.59	24.32	26.78	24.30
Net Profit	249	254	258	316	396	379	415	441	494	516
EPS in Rs	16.20	17.06	17.65	21.23	26.34	25.89	27.10	30.10	33.19	34.94

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	7,256	8,243	9,617	11,247	10,560	14,663	16,613	19,059	21,794	22,551
Expenses	6,527	7,450	8,554	9,660	9,423	12,478	14,563	16,669	18,772	19,352
Operating Profit	729	793	1,064	1,587	1,137	2,185	2,050	2,391	3,022	3,199
OPM %	10.04	9.62	11.06	14.11	10.77	14.90	12.34	12.54	13.87	14.18
Other Income	65	32	32	225	106	372	90	108	233	238
Interest	257	295	327	533	449	379	381	449	459	450
Depreciation	314	359	396	620	573	601	615	687	758	795
Profit Before Tax	222	171	373	660	221	1,578	1,144	1,363	2,039	2,192
Tax %	40.96	65.27	46.54	34.12	38.38	30.23	22.40	32.70	26.19	25.60
Net Profit	131	60	199	435	136	1,101	888	917	1,505	1,631
EPS in Rs	—	—	16.64	31.64	10.56	73.42	56.96	62.50	100.56	125.33
Dividend Payout %	37.78	59.24	35.38	18.35	27.93	16.00	26.33	25.60	12.59	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	70	70	70	70	70	72	72	72	72	72
Reserves	3,262	3,244	3,182	3,264	3,270	4,531	5,551	6,126	6,864	8,140
Borrowings	2,633	3,024	3,303	3,450	3,350	4,160	4,068	4,332	5,333	7,864
Other Liabilities	1,396	1,782	2,058	2,400	4,650	2,654	3,578	3,898	4,485	4,581
Total Liabilities	7,360	8,119	8,613	9,183	11,338	11,417	13,269	14,428	16,753	20,657
Fixed Assets	3,997	4,583	4,766	4,975	7,426	6,773	8,291	8,516	9,661	10,985
CWIP	562	347	712	822	236	234	46	610	873	921
Investments	352	414	359	468	440	1,348	821	578	990	2,490
Other Assets	2,448	2,775	2,776	2,918	3,237	3,062	4,112	4,725	5,230	6,261
Total Assets	7,360	8,119	8,613	9,183	11,338	11,417	13,269	14,428	16,753	20,657

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	597	623	537	905	1,293	1,265	1,696	1,377	1,920	2,136
Cash from Investing Activity	-888	-1,152	-405	-711	-289	-880	-747	-857	-1,537	-3,381
Cash from Financing Activity	330	477	-108	-215	-910	-340	-792	-633	-311	1,317
Net Cash Flow	39	-52	24	-20	95	44	158	-113	72	73

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.34%	29.34%	28.02%	28.02%
FIIs	46.96%	47.93%	46.15%	46.25%	45.63%	43.92%	45.37%	45.27%	42.74%	1.61%	44.20%	43.54%
DIIs	17.99%	17.24%	18.83%	19.10%	19.77%	21.37%	20.18%	20.20%	22.51%	21.57%	21.35%	21.74%
Public	5.71%	5.50%	5.69%	5.32%	5.26%	5.38%	5.12%	5.19%	5.41%	47.49%	6.43%	6.71%
Total Shareholders	1,31,937	1,20,030	1,31,565	1,19,578	1,30,664	1,27,754	1,19,245	1,27,802	1,34,058	1,41,007	1,60,556	1,78,648

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Projection

Unlock Premium Features

Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Available on Pro Plan